These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 23065921

  • 1. Knowledge translation for nephrologists: strategies for improving the identification of patients with proteinuria.
    Hemmelgarn BR, Manns BJ, Straus S, Naugler C, Holroyd-Leduc J, Braun TC, Levin A, Klarenbach S, Lee PF, Hafez K, Schwartz D, Jindal K, Ervin K, Bello A, Turin TC, McBrien K, Elliott M, Tonelli M, Interdisciplinary Chronic Disease Collaboration ICDC.
    J Nephrol; 2012; 25(6):933-43. PubMed ID: 23065921
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Awareness and implementation in daily practice of the S.E.N.-semFYC consensus document on chronic kidney disease.
    Egocheaga MI, Alcázar R, Lobos JM, Górriz JL, Martínez-Castelao A, Pastor A, Martínez I, Caballero F, Sánchez-Celaya M.
    Nefrologia; 2012 Jan; 32(6):797-808. PubMed ID: 23169363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.
    Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.
    Nefrologia; 2014 May 21; 34(3):302-16. PubMed ID: 24798565
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk management frameworks for human health and environmental risks.
    Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.
    J Toxicol Environ Health B Crit Rev; 2003 May 21; 6(6):569-720. PubMed ID: 14698953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.
    Belaiche S, Romanet T, Allenet B, Calop J, Zaoui P.
    J Nephrol; 2012 May 21; 25(5):782-8. PubMed ID: 22322820
    [Abstract] [Full Text] [Related]

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 21; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.